Generative methods, validation frameworks, and equity considerations of synthetic data in medical artificial intelligence

Abstract

Synthetic data is emerging as a strategic solution to persistent barriers in medical artificial intelligence (AI) development, including data scarcity, privacy constraints, and dataset bias. This perspective examines the landscape of synthetic multimodal data in healthcare, including its mechanisms, demonstrated benefits, technical and ethical challenges, and a proposed validation framework linking fidelity to clinical utility. We integrate evidence from recent empirical studies, the generative AI literature, and regulatory developments. We discuss how synthetic data is generated across four healthcare domains: medical imaging, electronic health records, clinical text, and genomics. We also review methods such as generative adversarial networks, diffusion models, large language models, and rule-based simulators. Synthetic multimodal data demonstrably improves AI model performance, addresses class imbalance, enables privacy- preserving data-sharing, and supports regulatory evaluation pathways. Illustrative case studies suggest potential gains in model performance, although systematic quantitative evidence across modalities remains limited. Key challenges include re-identification risks, the perpetuation of bias, computational inequity, and the absence of cross-modal coherence standards. A seven-dimensional validation scorecard is proposed, covering statistical fidelity, privacy risk, clinical utility, robustness, cross-modal coherence, and governance. Synthetic multimodal data can catalyze medical AI innovation, but only if paired with rigorous validation, transparent governance, and a firm commitment to equity. Priority actions include international benchmark consortia, regulatory sandboxes, investment in federated learning, and mandatory intersectional bias auditing.